Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,950,377 papers from all fields of science
Search
Sign In
Create Free Account
Vaccines, Acellular
Known as:
Acellular Vaccines
, Vaccines, Acellular [Chemical/Ingredient]
, acellular vaccine
Vaccines that are produced by using only the antigenic part of the disease causing organism. They often require a "booster" every few years to…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
In Blood
Process of secretion
agonists
antagonists & inhibitors
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Impact of vaccination against pertussis on the cases of coqueluche
Rosa Caroline Mata Verçosa
,
Thalita da Silva Pereira
2017
Corpus ID: 79927014
800x600 ABSTRACT Objective: to analyze the impact of vaccination against Pertussis on the number of pertussis cases. Method…
Expand
2014
2014
Recombinant hybrid proteins from pertactin type 1 and 2 of Bordetella pertussis are more immunogenic in mice than the original molecules
D. Quintana-Vázquez
,
E. Coizeau
,
+6 authors
G. Guillén
2014
Corpus ID: 7987112
The present study explores the concept of hybrid pertactin (PRN) molecules for immunizing against Bordetella pertussis. New…
Expand
2014
2014
Ensayos para evaluar la toxicidad de la toxina pertúsica en vacunas acelulares
Susana Miraidys Brito-Molina
2014
Corpus ID: 48435355
Resumen es: La toxina pertusica es el principal factor de virulencia producido por Bordetella pertussis y su forma detoxificada…
Expand
2010
2010
Expresión de las fimbrias Fim2 y Fim3 desde el plasmidio pMMB67 en cepas de Bordetella pertussis
Lourdes Proenza
,
Javier Campos
,
B. Ferrán
,
E. Marcos
,
Celso Pérez
2010
Corpus ID: 83043878
Resumen es: Bordetella pertussis, el agente etiologico de la tos ferina, produce dos tipos de fimbrias serologicamente diferentes…
Expand
2007
2007
New approaches in pertussis vaccines for developing countries
W. Dias
,
M. Sakauchi
,
F. Kubrusly
,
I. P. Nascimento
,
W. Quintilio
,
H. G. Higashi
2007
Corpus ID: 8220079
Divisao de Producao, Av. Vital Brazil, 1500, 05503-000, Sao Paulo, SP, Brasil The currently available pertussis vaccines are…
Expand
2006
2006
Clinical application of new-type allogenic acellular dermic skin grafts on scar contraction from burns
Yi Cheng-gang
2006
Corpus ID: 75636374
Objective To investigate the possibility of the new-type allogenic acellular dermic skin grafts to treat the wound of extremity…
Expand
2006
2006
Anabolic effects of acellular bon em arrow, platelet rich plasma ,a nd serum on equine suspensor yl igament fibroblast s in vitro
J. J. Smit
2006
Corpus ID: 113262275
Summary The purpose of this study wa st oi nvestigate th er esponse of suspensor yl igament fibroblast s( SLF) to in vitro…
Expand
1997
1997
Towards better pertussis vaccines.
B. Trollfors
,
J. Taranger
Annals medicus
1997
Corpus ID: 44824310
Several recently completed trials have shown that acellular pertussis vaccines induce substantial protection against pertussis…
Expand
1984
1984
Statement on pertussis vaccine.
EPI newsletter
1984
Corpus ID: 24868896
Vaccination is the only method of proven effectiveness for the control of whooping cough. Although effective, the vaccine is…
Expand
1979
1979
An acellular vaccine from Pseudomonas aeruginosa: homologous and crossed protection between serogroups according to Habs' classification.
P. Berche
,
M. Véron
,
J. Fermanian
,
F. Daoulas-Lebourdelles
,
A. Guégen
Annals of Microbiology
1979
Corpus ID: 25965941
Homologous and cross-reactions were studied in 16 strains of Pseudomonas aeruginosa belonging to different O serogroups according…
Expand